Loading…

OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome

Laryngeal dysplasia is a common clinical concern. Despite major advancements, a significant number of patients with this condition progress to invasive squamous cell carcinoma. Osteopontin (OPN) is a secreted glycoprotein, whose expression is markedly elevated in several types of cancers. We explore...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2007-12, Vol.97 (11), p.1545-1551
Main Authors: Staibano, S, Merolla, F, Testa, D, Iovine, R, Mascolo, M, Guarino, V, Castellone, M D, Di Benedetto, M, Galli, V, Motta, S, Melillo, R M, De Rosa, G, Santoro, M, Celetti, A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Laryngeal dysplasia is a common clinical concern. Despite major advancements, a significant number of patients with this condition progress to invasive squamous cell carcinoma. Osteopontin (OPN) is a secreted glycoprotein, whose expression is markedly elevated in several types of cancers. We explored OPN as a candidate biomarker for laryngeal dysplasia. To this aim, we examined OPN expression in 82 cases of dysplasia and in hyperplastic and normal tissue samples. OPN expression was elevated in all severe dysplasia samples, but not hyperplastic samples, with respect to matched normal mucosa. OPN expression levels correlated positively with degree of dysplasia ( P =0.0094) and negatively with disease-free survival ( P
ISSN:0007-0920
1532-1827
DOI:10.1038/sj.bjc.6604070